A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD Patients
Clinical trial NCT02671942 · TERMINATED
Trial details
- NCT number
- NCT02671942
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-06-13
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.